Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IHC 2021 | The development of the EHF consensus on resistant and refractory migraine

Simona Sacco, MD, University of L’Aquila, L’Aquila, Italy, describes the development of the European Headache Federation (EHF) consensus on the definition of resistant and refractory migraine. The Delphi method was used, and several rounds of questions were assigned to the panel members. After each round, the answers were sent to the facilitator, who collected all answers and issued a report with comments and agreement rates. Using the results of the Delphi questions, a step-by-step approach was used to build the definitions. This interview took place during the International Headache Congress 2021.

Disclosures

Eli Lilly, Teva, Novartis, Allergan-Abbvie, Abbott, AstraZeneca, NovoNordisk.